Botanical drug products approved as prescription drugs

STO-REC-STATNRSYQYT1 Official
4

United States · as of 3 Sep 2026

Botanical drug products approved as prescription drugs in United States stood at 4 as of 3 September 2026 (FDA).

Original source
Publisher
FDA
Authority tier
T1 Official
Locator
FDA Seeks Public Input to Advance Development of Botanical Drug Products
Retrieved
17 Sep 2026
Status
Verified

What the source says

To date, four botanical products have been approved for marketing as prescription drugs through the FDA’s new drug application and biologics license application pathways.

Verbatim extraction verified: The figure 4 is directly attested in the quoted passage (FDA Seeks Public Input to Advance Development of Botanical Drug Products).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
U.S. Food and Drug Administration. (2026). FDA Seeks Public Input to Advance Development of Botanical Drug Products. Retrieved September 17, 2026, from https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Via StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY
MLA
U.S. Food and Drug Administration. "FDA Seeks Public Input to Advance Development of Botanical Drug Products." 2026, https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY.
Chicago
U.S. Food and Drug Administration. "FDA Seeks Public Input to Advance Development of Botanical Drug Products." 2026. https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY.
BibTeX
@misc{fda2026botanical5dcgky, author = {{U.S. Food and Drug Administration}}, title = {FDA Seeks Public Input to Advance Development of Botanical Drug Products}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY}, note = {Original source: https://www.fda.gov/news-events/press-announcements/fda-seeks-public-input-advance-development-botanical-drug-products. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATNRSYQY T1 Official

Primary Source

Publisher
U.S. Food and Drug Administration · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
FDA Seeks Public Input to Advance Development of Botanical Drug Products
Type
Press release
Published
Locator
FDA Seeks Public Input to Advance Development of Botanical Drug Products
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_NRSYQY2AXZDY94AMEFRD5DCGKY